Sight Diagnostics® is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science.
Sight OLO®, is the first FDA 510(k) cleared CBC analyzer that takes blood directly from a fingerstick or venous sample. OLO uses a disposable cartridge, eliminating the need for reagent management and maintenance. The analyzer comes factory calibrated for a quick set-up with minimal training.
OLO has been validated for patients three months of age and above in a variety of CLIA certified moderately complex clinical settings such as oncology, pediatrics and urgent care settings. The possibility of processing finger prick samples in hospitals and clinics makes OLO perfectly accessible to the most delicate patients and situations.